Zobrazeno 1 - 10
of 303
pro vyhledávání: '"G. D. Kerr"'
Autor:
null P A F
Publikováno v:
Journal of Occupational and Environmental Medicine. 19:429
Autor:
M. D. Taylor, C. E. Emmas, G. D. Bell, A. T. R. Axon, G. D. Kerr, G. Tildesley, J. R. B. Green, C. M. Bate
Publikováno v:
Alimentary Pharmacology & Therapeutics. 9:513-520
SUMMARY Aims: To compare the efficacy, safety and tolerability of an omeprazole/amoxycillin (OA) dual therapy Helicobacter pylori eradication regimen with an omeprazole/amoxycillin/metronidazole (OAM) triple therapy regimen. Methods: In this double-b
Publikováno v:
Diabetic Medicine. 23:1313-1318
Aims To determine rate and predictors of mortality in patients with Type 2 diabetes living in a population with a large proportion of Maori and Pacific peoples who were admitted to hospital with myocardial infarction (MI) or congestive cardiac failur
Publikováno v:
Alimentary Pharmacology & Therapeutics. 19:435-442
Summary Background : The patient-centred approach is new to the management of ulcerative colitis. To date, it has only been shown to be successful in a short-term study. Aim : To assess the feasibility, safety and efficacy of patient-led dosing using
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:61-68
Background: Sulfasalazine is well established in the treatment of active ulcerative colitis. Intolerance to sulfasalazine, however, is a common problem. Balsalazide has been designed to deliver 5-aminosalicylic acid to the colon without the poor tole
Autor:
J. P. Crowe, M. D. Taylor, Alan J Lobo, K. J. Schofield, E. T. Swarbrick, C. D. Holdsworth, G. D. Kerr, J. R. B. Green, J. A. Gibson
Publikováno v:
Alimentary Pharmacology & Therapeutics. 12:1207-1216
Background: Despite widespread use of aminosalicylates as maintenance treatment for ulcerative colitis (UC), patients still report troublesome symptoms, often nocturnally. Aim: To compare the efficacy and safety of balsalazide (Colazide) with mesalaz
Autor:
M. D. Taylor, Roger J. Leicester, Alan J Lobo, J. R. B. Green, G. D. Kerr, Humphrey Hodgson, Charles D. Holdsworth, Katharine J. Parkins, John Gibson
Publikováno v:
Gastroenterology. 114:15-22
Background & Aims: Aminosalicylates are widely used in the treatment of ulcerative colitis (UC). Balsalazide is a novel mesalamine prodrug, activated by colonic bacteria. The aim of this study was to compare the efficacy and safety of balsalazide wit
Autor:
G. D. Kerr, B T Cooper, H Langworthy, D Piper, J. J. Misiewicz, S Levi, Colm O'Morain, Michael F. Dixon, K D Bardhan, A W Harris
Publikováno v:
Gut. 41:735-739
Background—Eradication ofHelicobacter pylori cures and prevents the relapse of duodenal ulceration and also results in histological resolution of chronic active gastritis. Aim—To compare four treatment regimens lasting seven days of a proton pump
Autor:
S. Johnston, Peter D. Howdle, G. D. Kerr, Richard S. Houlston, G. K. T. Holmes, A. H. G. Love, Andrew James Godkin, D. O'Donoghue, K. B. Hosie, J. A. Walker-Smith, A. Roberts, Anne Ferguson, Parveen Kumar, Sheila Seal, A Marossy, M. F. Stratton, D. Ford, Richard F A Logan, S. Mitton, Ian Tomlinson, Michael N. Marsh, Derek P. Jewell
Publikováno v:
Human Molecular Genetics. 6:1335-1339
A strong HLA association is seen in coeliac disease [specifically to the DQ(alpha1*0501,beta1*0201 heterodimer], but this cannot entirely account for the increased risk seen in relatives of affected cases. One or more genes at HLA-unlinked loci also
Autor:
Roy Cockel, G. D. Kerr, Peter D.I Richardson, W.Stuart Hislop, Paul M. Smith, Andrew Theodossi, Michael W Dronfield, M. D. Taylor, R.Jim McFarland, Colin M Bate, Deborah A Watts, Paul Brown, J. R. B. Green, Barry A Ross
Publikováno v:
Gastroenterology. 107:1312-1318
Background/Aims: Dilatation combined with subsequent pharmacological control of gastroesophageal reflux represents a logical but poorly documented approach to the management of benign esophageal stricture. This large trial (366 patients) aimed to ass